Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AG-348 in Adult Patients With Pyruvate Kinase Deficiency
NCT02476916Phase 2Completed
- Sponsor
- Agios Pharmaceuticals
- Start
- Jun 2015
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of mitapivat in pyruvate kinase deficiency (PKD), sponsored by Agios Pharmaceuticals. Started Jun 2015; status: completed.
02
Drugs
mitapivat
03
Conditions
pyruvate kinase deficiency (PKD)
Beyond the preview
Go deeper on NCT02476916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02476916.